Debbie Wasserman Schultz bought Keryx Biopharmaceuticals, Inc. (KERX) (KERX)
Debbie Wasserman Schultz (D-FL), a U.S. Representative, has disclosed 4 trades in Keryx Biopharmaceuticals, Inc. (KERX) (KERX) since 2016, all purchases, worth an estimated $32K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a purchase: Debbie Wasserman Schultz bought $1,001 - $15,000 of Keryx Biopharmaceuticals, Inc. (KERX) (KERX) on April 27, 2016. Since that trade, KERX is up +0.00% against the S&P 500 up +310.14%, an outperformance of -310.14%.
Across these filings, Debbie Wasserman Schultz has been a net buyer of KERX. The most recent disclosed KERX transaction shown was dated February 10, 2017. Each row in the table below links to that trade and its post-trade performance versus the market.
Data updated
Debbie Wasserman Schultz's KERX trades vs the price
KERX is up +0.00% since Debbie Wasserman Schultz bought on April 27, 2016, versus +310.14% for the S&P 500.
Performance since this trade
All Debbie Wasserman Schultz KERX trades
| Traded | Type | Size | Return | Est. profit | |
|---|---|---|---|---|---|
| February 10, 2017 | BUY | $1,001 - $15,000 | N/A | — | |
| December 12, 2016 | BUY | $1,001 - $15,000 | N/A | — | |
| December 12, 2016 | BUY | $1,001 - $15,000 | N/A | — | |
| April 27, 2016 | BUY | $1,001 - $15,000 | N/A | — |
Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.
Debbie Wasserman Schultz & KERX trading FAQ
Is it legal for Debbie Wasserman Schultz to trade Keryx Biopharmaceuticals, Inc. (KERX) (KERX) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Keryx Biopharmaceuticals, Inc. (KERX) (KERX), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Debbie Wasserman Schultz buy KERX?
Debbie Wasserman Schultz disclosed a purchase of $1,001 - $15,000 of Keryx Biopharmaceuticals, Inc. (KERX) (KERX) on April 27, 2016, according to public STOCK Act filings.
How has KERX performed since Debbie Wasserman Schultz's trade?
Since Debbie Wasserman Schultz bought KERX on April 27, 2016, the stock is up +0.00%, versus +310.14% for the S&P 500 over the same period, an outperformance of -310.14%.
How many times has Debbie Wasserman Schultz traded KERX?
Debbie Wasserman Schultz has disclosed 4 KERX trades since 2016. Every disclosed trade is listed on this page.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional KERX trades?
Quantellect tracks every disclosed congressional trade in Keryx Biopharmaceuticals, Inc. (KERX) (KERX) on the Keryx Biopharmaceuticals, Inc. (KERX) congressional trading page, which aggregates filings across all members of Congress.
Debbie Wasserman Schultz's KERX tradesAll congressional filings for Keryx Biopharmaceuticals, Inc. (KERX)Debbie Wasserman Schultz's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.